Cited by 433Pancreatic and Hepatic Oncology ResearchSingle-cell and spatial transcriptomicsCancer Genomics and Diagnostics

Spatially confined sub-tumor microenvironments in pancreatic cancer

Open access
Grünwald, Barbara T., Devisme, Antoine, Andrieux, Geoffroy, Vyas, Foram, Aliar, Kazeera, McCloskey, Curtis W., Macklin, Andrew, Jang, Gun Ho +16 more·2021·Cell

Published version of a preprint

Abstract

Intratumoral heterogeneity is a critical frontier in understanding how the tumor microenvironment (TME) propels malignant progression. Here, we deconvolute the human pancreatic TME through large-scale integration of histology-guided regional multiOMICs with clinical data and patient-derived preclinical models. We discover "subTMEs," histologically definable tissue states anchored in fibroblast plasticity, with regional relationships to tumor immunity, subtypes, differentiation, and treatment response. "Reactive" subTMEs rich in complex but functionally coordinated fibroblast communities were immune hot and inhabited by aggressive tumor cell phenotypes. The matrix-rich "deserted" subTMEs harbored fewer activated fibroblasts and tumor-suppressive features yet were markedly chemoprotective and enriched upon chemotherapy. SubTMEs originated in fibroblast differentiation trajectories, and transitory states were notable both in single-cell transcriptomics and in situ. The intratumoral co-occurrence of subTMEs produced patient-specific phenotypic and computationally predictable heterogeneity tightly linked to malignant biology. Therefore, heterogeneity within the plentiful, notorious pancreatic TME is not random but marks fundamental tissue organizational units.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2021.09.022

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fibroblast status during tumorigenesis and progression can be influenced by genetic mutations present in PDAC cells.

    “fibroblast status throughout tumorigenesis and progression can be influenced by genetic mutations present in the PDAC cells154,155”

    From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [155]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Grünwald, B. T., Devisme, A., Andrieux, G., Vyas, F., Aliar, K., McCloskey, C. W., Macklin, A., Jang, G. H., Denroche, R., Romero, J. M., Bavi, P., Bronsert, P., Notta, F., O’Kane, G., Wilson, J., Knox, J., Tamblyn, L., Udaskin, M., Radulovich, N., Fischer, S. E., Boerries, M., Gallinger, S., Kislinger, T., & Khokha, R.
Affiliations
  • University Health Network (CA)
  • University of Freiburg (DE)
  • Ontario Institute for Cancer Research (CA)
Corresponding author
  • Boerries, Melanie
  • Kislinger, Thomas
  • Khokha, Rama
Venue
Cell
Publisher
Elsevier BV
Published
2021-10
Volume
184
Issue
22
Pages
5577-5592.e18
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3206996158
Cited by
433
References
56
Citations by year
2026: 76 · 2025: 95 · 2024: 97 · 2023: 98 · 2022: 61 · 2021: 5
FWCI
24.65
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
Funders
  • Alexander von Humboldt-Stiftung (DEU‐1199182‐FLFP, DEU 1199182)
  • Princess Margaret Cancer Foundation (DEU 1199182 FLF-P, ALTF 116-2018)
  • Ontario Institute for Cancer Research
  • Government of Ontario
  • Pancreatic Cancer Canada Foundation
  • Deutsche Forschungsgemeinschaft (FKZ 01ZZ1801B, SFB850)
  • Bundesministerium für Bildung und Forschung (01ZZ1801B, Fkz. 01ZZ1801B)
  • Terry Fox Research Institute
  • Canadian Cancer Society Research Institute
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
pancreatic cancer, tumor microenvironment, intratumoral heterogeneity, fibroblast plasticity, antitumor immunity, chemotherapy response, tumor cell phenotype, multi-omics integration, single-cell transcriptomics
MeSH terms
Cancer-Associated Fibroblasts, Adenocarcinoma, Cell Differentiation, Epithelium, Extracellular Matrix, Female, Humans, Male, Middle Aged, Pancreatic Neoplasms, Phenotype, Gene Expression Regulation, Neoplastic, Survival Analysis, Stromal Cells, Gene Expression Profiling, Carcinoma, Pancreatic Ductal, Cell Proliferation, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review